NOT FOR DISTRIBUTION
Header cover image

MCI Onehealth Technologies

Market Cap

CA$135.9m

Last Updated

2021/05/12 23:09 UTC

Data Sources

Company Financials +

Executive Summary

MCI Onehealth Technologies Inc., through its subsidiaries, provides healthcare and healthcare related services to patients and the employees of corporate customers in Canada. More Details

Rewards

Earnings are forecast to grow 61.37% per year

Risk Analysis

No risks detected for DRDR from our risk checks.


Snowflake Analysis

Reasonable growth potential with imperfect balance sheet.


Similar Companies

Share Price & News

How has MCI Onehealth Technologies's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: DRDR is not significantly more volatile than the rest of Canadian stocks over the past 3 months, typically moving +/- 10% a week.

Volatility Over Time: Insufficient data to determine DRDR's volatility change over the past year.


Market Performance


7 Day Return

-5.3%

DRDR

-0.8%

CA Healthcare

-0.8%

CA Market


1 Year Return

n/a

DRDR

37.5%

CA Healthcare

38.7%

CA Market

Return vs Industry: Insufficient data to determine how DRDR performed against the Canadian Healthcare industry.

Return vs Market: Insufficient data to determine how DRDR performed against the Canadian Market.


Shareholder returns

DRDRIndustryMarket
7 Day-5.3%-0.8%-0.8%
30 Day-9.8%-4.1%0.2%
90 Day-7.2%-3.4%5.5%
1 Yearn/a41.8%37.5%43.3%38.7%
3 Yearn/a41.7%23.8%27.3%15.2%
5 Yearn/a10.4%-13.5%57.2%33.6%

Long-Term Price Volatility Vs. Market

How volatile is MCI Onehealth Technologies's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is MCI Onehealth Technologies undervalued compared to its fair value and its price relative to the market?

996.49x

Price to Book (PB) ratio


Share Price vs. Fair Value

Below Fair Value: Insufficient data to calculate DRDR's fair value to establish if it is undervalued.

Significantly Below Fair Value: Insufficient data to calculate DRDR's fair value to establish if it is undervalued.


Price To Earnings Ratio

PE vs Industry: DRDR is unprofitable, so we can't compare its PE Ratio to the Canadian Healthcare industry average.

PE vs Market: DRDR is unprofitable, so we can't compare its PE Ratio to the Canadian market.


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate DRDR's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: DRDR is overvalued based on its PB Ratio (996.5x) compared to the CA Healthcare industry average (4.2x).


Future Growth

How is MCI Onehealth Technologies forecast to perform in the next 1 to 3 years based on estimates from 2 analysts?

61.4%

Forecasted annual earnings growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: DRDR is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (1.5%).

Earnings vs Market: DRDR is forecast to become profitable over the next 3 years, which is considered above average market growth.

High Growth Earnings: DRDR's is expected to become profitable in the next 3 years.

Revenue vs Market: DRDR's revenue (14.2% per year) is forecast to grow faster than the Canadian market (6.5% per year).

High Growth Revenue: DRDR's revenue (14.2% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if DRDR's Return on Equity is forecast to be high in 3 years time


Past Performance

How has MCI Onehealth Technologies performed over the past 5 years?

-776.9%

Last years earnings growth


Earnings and Revenue History

Quality Earnings: DRDR is currently unprofitable.

Growing Profit Margin: DRDR is currently unprofitable.


Past Earnings Growth Analysis

Earnings Trend: Insufficient data to determine if DRDR's year-on-year earnings growth rate was positive over the past 5 years.

Accelerating Growth: Unable to compare DRDR's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: DRDR is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (97.3%).


Return on Equity

High ROE: DRDR has a negative Return on Equity (-433.33%), as it is currently unprofitable.


Financial Health

How is MCI Onehealth Technologies's financial position?


Financial Position Analysis

Short Term Liabilities: DRDR's short term assets (CA$5.8M) do not cover its short term liabilities (CA$10.7M).

Long Term Liabilities: DRDR's short term assets (CA$5.8M) do not cover its long term liabilities (CA$11.4M).


Debt to Equity History and Analysis

Debt Level: DRDR's debt to equity ratio (510.5%) is considered high.

Reducing Debt: Insufficient data to determine if DRDR's debt to equity ratio has reduced over the past 5 years.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: Whilst unprofitable DRDR has sufficient cash runway for more than 3 years if it maintains its current positive free cash flow level.

Forecast Cash Runway: DRDR is unprofitable but has sufficient cash runway for more than 3 years, due to free cash flow being positive and growing by 9.6% per year.


Dividend

What is MCI Onehealth Technologies's current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

Notable Dividend: Unable to evaluate DRDR's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate DRDR's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if DRDR's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if DRDR's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of DRDR's dividend in 3 years as they are not forecast to pay a notable one for the Canadian market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

0.7yrs

Average board tenure


CEO

Alex Dobranowski

0.67

Tenure

Dr. Alexander Julian Dobranowski, also known as Alex, is a Founder of MCI Onehealth Technologies Inc. and serves as its Chief Executive Officer and Director since September 01, 2020. With years of speciali...


Board Members

Experienced Board: DRDR's board of directors are not considered experienced ( 0.7 years average tenure), which suggests a new board.


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: DRDR insiders have bought more shares than they have sold in the past 3 months.


Recent Insider Transactions

Ownership Breakdown

Dilution of Shares: DRDR only recently listed within the past 12 months.


Top Shareholders

Company Information

MCI Onehealth Technologies Inc.'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: MCI Onehealth Technologies Inc.
  • Ticker: DRDR
  • Exchange: TSX
  • Founded: 2012
  • Industry: Health Care Services
  • Sector: Healthcare
  • Market Cap: CA$135.880m
  • Shares outstanding: 48.70m
  • Website: https://www.mcionehealth.com

Number of Employees


Location

  • MCI Onehealth Technologies Inc.
  • 1 Yorkdale Road
  • Suite 209
  • Toronto
  • Ontario
  • M6A 3A1
  • Canada

Listings


Biography

MCI Onehealth Technologies Inc., through its subsidiaries, provides healthcare and healthcare related services to patients and the employees of corporate customers in Canada. The company provides its servi...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2021/05/12 23:09
End of Day Share Price2021/05/12 00:00
Earnings2020/12/31
Annual Earnings2020/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.